Project Title: A Phase IIb Multicenter, Observer-Blinded, Randomized, Placebo-Controlled Trial to Evaluate the Immunogenicity and Safety of the AdCLD-CoV19-1 in Healthy Adults aged 19 years old and above

Project Description: A Phase IIb Multicenter, Observer-Blinded, Randomized, Placebo-Controlled Trial to Evaluate the Immunogenicity and Safety of the AdCLD-CoV19-1 in Healthy Adults aged 19 years old and above A Phase IIb Multicenter, Observer-Blinded, Randomized, Placebo-Controlled Trial to Evaluate the Immunogenicity and Safety of the AdCLD-CoV19-1 in Healthy Adults aged 19 years old and above Read more

Principal Investigator : Jerry Hella

Department Name :

Time frame: (2022-06-01) - (2022-11-08)

Funding Partners
None added yet.
External Collaborating Partners
None added yet.